{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:33:16Z","timestamp":1773675196398,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T00:00:00Z","timestamp":1410220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T00:00:00Z","timestamp":1410220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nicotinamide phosphoribosyltransferase (NAMPT) and nicotinate phosphoribosyltransferase domain containing 1 (NAPRT1) are the main human NAD salvage enzymes. NAD regulates energy metabolism and cell signaling and the enzymes that control NAD availability are linked to pathologies such as cancer and neurodegeneration. Here, we have screened normal and tumor samples from different tissues and populations of origin for mutations in human <jats:italic>NAMPT<\/jats:italic> and <jats:italic>NAPRT1<\/jats:italic> and evaluated their potential pathogenicity. We have identified several novel polymorphisms and showed that <jats:italic>NAPRT1<\/jats:italic> has a greater genetic diversity than <jats:italic>NAMPT<\/jats:italic>, where any alteration can have a greater functional impact. Some variants presented different frequencies between normal and tumor samples that were most likely related to their population of origin. The novel mutations described that affect protein structure or expression levels can be functionally relevant and should be considered in a disease context. Particularly, mutations that decrease NAPRT1 expression can predict the usefulness of Nicotinic Acid in tumor treatments with NAMPT inhibitors.<\/jats:p>","DOI":"10.1038\/srep06311","type":"journal-article","created":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T09:05:05Z","timestamp":1410253505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["NAMPT and NAPRT1: novel polymorphisms and distribution of variants between normal tissues and tumor samples"],"prefix":"10.1038","volume":"4","author":[{"given":"Sara","family":"Duarte-Pereira","sequence":"first","affiliation":[]},{"given":"Sarah S.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Lu\u00edsa","family":"Azevedo","sequence":"additional","affiliation":[]},{"given":"Lu\u00edsa","family":"Castro","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Amorim","sequence":"additional","affiliation":[]},{"given":"Raquel M.","family":"Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,9,9]]},"reference":[{"key":"BFsrep06311_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/JTO.0b013e318233d686","volume":"7","author":"S Okumura","year":"2012","unstructured":"Okumura, S., Sasaki, T., Minami, Y. & Ohsaki, Y. Nicotinamide phosphoribosyltransferase: a potent therapeutic target in non-small cell lung cancer with epidermal growth factor receptor-gene mutation. J. Thorac. Oncol. 7, 49\u201356 (2012).","journal-title":"J. Thorac. Oncol."},{"key":"BFsrep06311_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00018-003-3161-1","volume":"61","author":"G Magni","year":"2004","unstructured":"Magni, G. et al. Enzymology of NAD+ homeostasis in man. Cell. Mol. Life Sci. 61, 19\u201334 (2004).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFsrep06311_CR3","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1371\/journal.pbio.0050263","volume":"5","author":"W Tempel","year":"2007","unstructured":"Tempel, W. et al. Nicotinamide riboside kinase structures reveal new pathways to NAD+. PLoS Biol. 5, e263 (2007).","journal-title":"PLoS Biol."},{"key":"BFsrep06311_CR4","doi-asserted-by":"publisher","first-page":"24574","DOI":"10.1074\/jbc.M610357200","volume":"282","author":"N Hara","year":"2007","unstructured":"Hara, N. et al. Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells. J. Biol. Chem. 282, 24574\u201324582 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFsrep06311_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrc3340","volume":"12","author":"A Chiarugi","year":"2012","unstructured":"Chiarugi, A., Dolle, C., Felici, R. & Ziegler, M. The NAD metabolome - a key determinant of cancer cell biology. Nat. Rev. Cancer 12, 741\u2013752 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"BFsrep06311_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.tibs.2006.11.006","volume":"32","author":"P Belenky","year":"2007","unstructured":"Belenky, P., Bogan, K. L. & Brenner, C. NAD+ metabolism in health and disease. Trends Biochem. Sci. 32, 12\u201319 (2007).","journal-title":"Trends Biochem. Sci."},{"key":"BFsrep06311_CR7","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/hmg\/ddt016","volume":"22","author":"A Ocampo","year":"2013","unstructured":"Ocampo, A., Liu, J. & Barrientos, A. NAD+ salvage pathway proteins suppress proteotoxicity in yeast models of neurodegeneration by promoting the clearance of misfolded\/oligomerized proteins. Hum. Mol. Genet. 22, 1699\u20131708 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"BFsrep06311_CR8","first-page":"3047","volume":"33","author":"R Shackelford","year":"2013","unstructured":"Shackelford, R. et al. Nicotinamide phosphoribosyltransferase and SIRT3 expression are increased in well-differentiated thyroid carcinomas. Anticancer Res. 33, 3047\u20133052 (2013).","journal-title":"Anticancer Res."},{"key":"BFsrep06311_CR9","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1128\/MCB.14.2.1431","volume":"14","author":"B Samal","year":"1994","unstructured":"Samal, B. et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol. Cell. Biol. 14, 1431\u20131437 (1994).","journal-title":"Mol. Cell. Biol."},{"key":"BFsrep06311_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1126\/science.1097243","volume":"307","author":"A Fukuhara","year":"2005","unstructured":"Fukuhara, A. et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307, 426\u2013430 (2005).","journal-title":"Science"},{"key":"BFsrep06311_CR11","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1002\/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L","volume":"32","author":"A Rongvaux","year":"2002","unstructured":"Rongvaux, A. et al. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur. J. Immunol. 32, 3225\u20133234 (2002).","journal-title":"Eur. J. Immunol."},{"key":"BFsrep06311_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev-nutr-071811-150746","volume":"32","author":"TB Dahl","year":"2012","unstructured":"Dahl, T. B., Holm, S., Aukrust, P. & Halvorsen, B. Visfatin\/NAMPT: a multifaceted molecule with diverse roles in physiology and pathophysiology. Annu. Rev. Nutr. 32, 229\u2013243 (2012).","journal-title":"Annu. Rev. Nutr."},{"key":"BFsrep06311_CR13","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1158\/1535-7163.MCT-09-1130","volume":"9","author":"UH Olesen","year":"2010","unstructured":"Olesen, U. H., Thougaard, A. V., Jensen, P. B. & Sehested, M. A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor. Mol. Cancer Ther. 9, 1609\u20131617 (2010).","journal-title":"Mol. Cancer Ther."},{"key":"BFsrep06311_CR14","doi-asserted-by":"publisher","first-page":"5872","DOI":"10.1128\/MCB.00112-09","volume":"29","author":"M Watson","year":"2009","unstructured":"Watson, M. et al. The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors. Mol. Cell. Biol. 29, 5872\u20135888 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"BFsrep06311_CR15","doi-asserted-by":"publisher","first-page":"6912","DOI":"10.1158\/1078-0432.CCR-13-1186","volume":"19","author":"DS Shames","year":"2013","unstructured":"Shames, D. S. et al. Loss of NAPRT1 Expression by Tumor-Specific Promoter Methylation Provides a Novel Predictive Biomarker for NAMPT Inhibitors. Clin. Cancer Res. 19, 6912\u20136923 (2013).","journal-title":"Clin. Cancer Res."},{"key":"BFsrep06311_CR16","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1210\/jc.2006-0149","volume":"91","author":"Y Bottcher","year":"2006","unstructured":"Bottcher, Y. et al. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans. J. Clin. Endocrinol. Metab. 91, 2725\u20132731 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFsrep06311_CR17","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/j.1464-5491.2006.01909.x","volume":"23","author":"WX Jian","year":"2006","unstructured":"Jian, W. X. et al. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population. Diabet. Med. 23, 967\u2013973 (2006).","journal-title":"Diabet. Med."},{"key":"BFsrep06311_CR18","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4161\/cbt.7.5.5663","volume":"7","author":"PS Reddy","year":"2008","unstructured":"Reddy, P. S. et al. PBEF1\/NAmPRTase\/Visfatin: a potential malignant astrocytoma\/glioblastoma serum marker with prognostic value. Cancer Biol. Ther. 7, 663\u2013668 (2008).","journal-title":"Cancer Biol. Ther."},{"key":"BFsrep06311_CR19","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s11033-010-0171-6","volume":"38","author":"LS Wang","year":"2011","unstructured":"Wang, L. S. et al. A polymorphism in the visfatin gene promoter is related to decreased plasma levels of inflammatory markers in patients with coronary artery disease. Mol. Biol. Rep. 38, 819\u2013825 (2011).","journal-title":"Mol. Biol. Rep."},{"key":"BFsrep06311_CR20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.metabol.2007.01.009","volume":"56","author":"A Korner","year":"2007","unstructured":"Korner, A. et al. Effects of genetic variation in the visfatin gene (PBEF1) on obesity, glucose metabolism and blood pressure in children. Metabolism 56, 772\u2013777 (2007).","journal-title":"Metabolism"},{"key":"BFsrep06311_CR21","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.2337\/db06-0189","volume":"55","author":"SD Bailey","year":"2006","unstructured":"Bailey, S. D. et al. Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population. Diabetes 55, 2896\u20132902 (2006).","journal-title":"Diabetes"},{"key":"BFsrep06311_CR22","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.metabol.2008.06.011","volume":"57","author":"LM Johansson","year":"2008","unstructured":"Johansson, L. M., Johansson, L. E. & Ridderstrale, M. The visfatin (PBEF1) G-948T gene polymorphism is associated with increased high-density lipoprotein cholesterol in obese subjects. Metabolism 57, 1558\u20131562 (2008).","journal-title":"Metabolism"},{"key":"BFsrep06311_CR23","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1002\/ajmg.b.30869","volume":"147B","author":"J Lasky-Su","year":"2008","unstructured":"Lasky-Su, J. et al. Genome-wide association scan of the time to onset of attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B, 1355\u20131358 (2008).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"BFsrep06311_CR24","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1093\/hmg\/ddq392","volume":"19","author":"A Murphy","year":"2010","unstructured":"Murphy, A. et al. Mapping of numerous disease-associated expression polymorphisms in primary peripheral blood CD4+ lymphocytes. Hum. Mol. Genet. 19, 4745\u20134757 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"BFsrep06311_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ncomms1033","volume":"1","author":"J Li","year":"2010","unstructured":"Li, J. et al. Identification of high-quality cancer prognostic markers and metastasis network modules. Nat. Commun. 1, 34 (2010).","journal-title":"Nat. Commun."},{"key":"BFsrep06311_CR26","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cell.2014.01.051","volume":"156","author":"F Supek","year":"2014","unstructured":"Supek, F., Minana, B., Valcarcel, J., Gabaldon, T. & Lehner, B. Synonymous mutations frequently act as driver mutations in human cancers. Cell 156, 1324\u20131335 (2014).","journal-title":"Cell"},{"key":"BFsrep06311_CR27","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.str.2005.05.016","volume":"13","author":"JS Chappie","year":"2005","unstructured":"Chappie, J. S. et al. The structure of a eukaryotic nicotinic acid phosphoribosyltransferase reveals structural heterogeneity among type II PRTases. Structure 13, 1385\u20131396 (2005).","journal-title":"Structure"},{"key":"BFsrep06311_CR28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1101\/gr.176601","volume":"11","author":"PC Ng","year":"2001","unstructured":"Ng, P. C. & Henikoff, S. Predicting deleterious amino acid substitutions. Genome Res. 11, 863\u2013874 (2001).","journal-title":"Genome Res."},{"key":"BFsrep06311_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248\u2013249 (2010).","journal-title":"Nat. Methods"},{"key":"BFsrep06311_CR30","doi-asserted-by":"publisher","first-page":"13748","DOI":"10.1073\/pnas.0903898106","volume":"106","author":"ES Burgos","year":"2009","unstructured":"Burgos, E. S., Ho, M. C., Almo, S. C. & Schramm, V. L. A phosphoenzyme mimic, overlapping catalytic sites and reaction coordinate motion for human NAMPT. Proc. Natl. Acad. Sci. U S A 106, 13748\u201313753 (2009).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"BFsrep06311_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1758-5996-2-21","volume":"2","author":"P Saddi-Rosa","year":"2010","unstructured":"Saddi-Rosa, P., Oliveira, C. S., Giuffrida, F. M. & Reis, A. F. Visfatin, glucose metabolism and vascular disease: a review of evidence. Diabetol. Metab. Syndr. 2, 21 (2010).","journal-title":"Diabetol. Metab. Syndr."},{"key":"BFsrep06311_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4172\/1948-593X.1000038","volume":"3","author":"LQ Zhang","year":"2011","unstructured":"Zhang, L. Q., Heruth, D. P. & Ye, S. Q. Nicotinamide Phosphoribosyltransferase in Human Diseases. J. Bioanal. Biomed. 3, 13\u201325 (2011).","journal-title":"J. Bioanal. Biomed."},{"key":"BFsrep06311_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.dsx.2013.06.001","volume":"7","author":"J Stastny","year":"2013","unstructured":"Stastny, J. et al. Association of genetic variability in selected regions in visfatin (NAMPT) gene with anthropometric parameters and dietary composition in obese and non-obese Central-European population. Diabetes Metab. Syndr. 7, 166\u2013171 (2013).","journal-title":"Diabetes Metab. Syndr."},{"key":"BFsrep06311_CR34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrg3051","volume":"12","author":"ZE Sauna","year":"2011","unstructured":"Sauna, Z. E. & Kimchi-Sarfaty, C. Understanding the contribution of synonymous mutations to human disease. Nat. Rev. Genet. 12, 683\u2013691 (2011).","journal-title":"Nat. Rev. Genet."},{"key":"BFsrep06311_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310\u2013315 (2014).","journal-title":"Nat. Genet."},{"key":"BFsrep06311_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0022-2836(91)90380-O","volume":"220","author":"S Brunak","year":"1991","unstructured":"Brunak, S., Engelbrecht, J. & Knudsen, S. Prediction of human mRNA donor and acceptor sites from the DNA sequence. J. Mol. Biol. 220, 49\u201365 (1991).","journal-title":"J. Mol. Biol."},{"key":"BFsrep06311_CR37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1600-0463.2011.02733.x","volume":"119","author":"UH Olesen","year":"2011","unstructured":"Olesen, U. H., Hastrup, N. & Sehested, M. Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas. APMIS 119, 296\u2013303 (2011).","journal-title":"APMIS"},{"key":"BFsrep06311_CR38","doi-asserted-by":"publisher","first-page":"22408","DOI":"10.1074\/jbc.M112.357301","volume":"287","author":"D Cerna","year":"2012","unstructured":"Cerna, D. et al. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner. J. Biol. Chem. 287, 22408\u201322417 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFsrep06311_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature13005","volume":"508","author":"G Hemani","year":"2014","unstructured":"Hemani, G. et al. Detection and replication of epistasis influencing transcription in humans. Nature 508, 249\u2013253 (2014).","journal-title":"Nature"},{"key":"BFsrep06311_CR40","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nsmb1114","volume":"13","author":"T Wang","year":"2006","unstructured":"Wang, T. et al. Structure of Nampt\/PBEF\/visfatin, a mammalian NAD+ biosynthetic enzyme. Nat. Struct. Mol. Biol. 13, 661\u2013662 (2006).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFsrep06311_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/jb\/mvp152","volume":"147","author":"R Takahashi","year":"2010","unstructured":"Takahashi, R. et al. Structure and reaction mechanism of human nicotinamide phosphoribosyltransferase. J. Biochem. 147, 95\u2013107 (2010).","journal-title":"J. Biochem."},{"key":"BFsrep06311_CR42","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.biochi.2011.06.033","volume":"94","author":"L Galassi","year":"2012","unstructured":"Galassi, L. et al. Characterization of human nicotinate phosphoribosyltransferase: Kinetic studies, structure prediction and functional analysis by site-directed mutagenesis. Biochimie 94, 300\u2013309 (2012).","journal-title":"Biochimie"},{"key":"BFsrep06311_CR43","doi-asserted-by":"publisher","first-page":"D348","DOI":"10.1093\/nar\/gks1243","volume":"41","author":"A Marchler-Bauer","year":"2013","unstructured":"Marchler-Bauer, A. et al. CDD: conserved domains and protein three-dimensional structure. Nucleic Acids Res. 41, D348\u2013352 (2013).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep06311_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1146\/annurev.nutr.28.061807.155443","volume":"28","author":"KL Bogan","year":"2008","unstructured":"Bogan, K. L. & Brenner, C. Nicotinic acid, nicotinamide and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu. Rev. Nutr. 28, 115\u2013130 (2008).","journal-title":"Annu. Rev. Nutr."},{"key":"BFsrep06311_CR45","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/nar\/gkh340","volume":"32","author":"RC Edgar","year":"2004","unstructured":"Edgar, R. C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792\u20131797 (2004).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep06311_CR46","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","volume":"25","author":"SF Altschul","year":"1997","unstructured":"Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389\u20133402 (1997).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep06311_CR47","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/prot.340230306","volume":"23","author":"A Sali","year":"1995","unstructured":"Sali, A., Potterton, L., Yuan, F., van Vlijmen, H. & Karplus, M. Evaluation of comparative protein modeling by MODELLER. Proteins 23, 318\u2013326 (1995).","journal-title":"Proteins"},{"key":"BFsrep06311_CR48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2105-9-40","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9, 40 (2008).","journal-title":"BMC Bioinformatics"},{"key":"BFsrep06311_CR49","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nprot.2010.5","volume":"5","author":"A Roy","year":"2010","unstructured":"Roy, A., Kucukural, A. & Zhang, Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 5, 725\u2013738 (2010).","journal-title":"Nat. Protoc."},{"key":"BFsrep06311_CR50","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/prot.340170404","volume":"17","author":"MJ Sippl","year":"1993","unstructured":"Sippl, M. J. Recognition of errors in three-dimensional structures of proteins. Proteins 17, 355\u2013362 (1993).","journal-title":"Proteins"},{"key":"BFsrep06311_CR51","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein, M. & Sippl, M. J. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 35, W407\u2013410 (2007).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep06311_CR52","unstructured":"Schrodinger, L. L. C. The PyMOL Molecular Graphics System, Version 1.3r1 (2010)."},{"key":"BFsrep06311_CR53","doi-asserted-by":"publisher","first-page":"D749","DOI":"10.1093\/nar\/gkt1196","volume":"42","author":"P Flicek","year":"2014","unstructured":"Flicek, P. et al. Ensembl 2014. Nucleic Acids Res. 42, D749\u2013755 (2014).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep06311_CR54","doi-asserted-by":"crossref","unstructured":"1000 Genomes Project, Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56\u201365 (2012).","DOI":"10.1038\/nature11632"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep06311","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep06311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep06311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T07:51:32Z","timestamp":1672991492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep06311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,9]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep06311"],"URL":"https:\/\/doi.org\/10.1038\/srep06311","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,9]]},"assertion":[{"value":"5 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6311"}}